Advocacy
Learn more about the Association's advocacy efforts to ensure patient
access to therapies.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
May 1, 2020
Physicians in European Plasma Collection Centers
Many European countries have regulatory systems, which require the presence of a physician at all times in plasma collection centers.
All
Advocacy
https://plasmaprotein.sharepoint.com/:b:/s/EU/EUlhH2KT7FtCh5puxKTq7oQB2LUBty3vutdZqorv3FK8_w?e=lQ7y56
May 1, 2020
Physicians in European Plasma Collection Centers
Many European countries have regulatory systems, which require the presence of a physician at all times in plasma collection centers.
All
Advocacy
https://plasmaprotein.sharepoint.com/:b:/s/EU/EUlhH2KT7FtCh5puxKTq7oQB2LUBty3vutdZqorv3FK8_w?e=lQ7y56
Dec 20, 2018
International Pricing Index Model for Medicare Part B Comments
The Plasma Protein Therapeutics Association (PPTA) is pleased to comment on the Advance Notice of Proposed Rulemaking regarding the International Pricing Index Model (Model) for Medicare Part B Drugs.1 PPTA is the standard setting and global advocacy organization that represents plasma donation centers and manufacturers of plasma protein therapies.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa1e482b183f5309ec39_PPTA%20Comments%20on%20the%20International%20Pricing%20Index%20Model%20for%20Medicare%20Part%20B%20Drugs.pdf
Dec 20, 2018
International Pricing Index Model for Medicare Part B Comments
The Plasma Protein Therapeutics Association (PPTA) is pleased to comment on the Advance Notice of Proposed Rulemaking regarding the International Pricing Index Model (Model) for Medicare Part B Drugs.1 PPTA is the standard setting and global advocacy organization that represents plasma donation centers and manufacturers of plasma protein therapies.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa1e482b183f5309ec39_PPTA%20Comments%20on%20the%20International%20Pricing%20Index%20Model%20for%20Medicare%20Part%20B%20Drugs.pdf
Dec 5, 2018
Senate of Canada Standing Committee on Social Affairs, Science, and Technology Testimony on Bill S-252
I am Josh Penrod, Senior Vice President at the Plasma Protein Therapeutics Association or PPTA. We are a trade association representing more than 700 source plasma collection centers in North America, including here in Canada, and in Europe, as well as the manufacturers of life-saving plasma protein therapies.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa57dbd7fb4143889316_Senate_of_Canada_Standing_Committee_on_Social.pdf
Dec 5, 2018
Senate of Canada Standing Committee on Social Affairs, Science, and Technology Testimony on Bill S-252
I am Josh Penrod, Senior Vice President at the Plasma Protein Therapeutics Association or PPTA. We are a trade association representing more than 700 source plasma collection centers in North America, including here in Canada, and in Europe, as well as the manufacturers of life-saving plasma protein therapies.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa57dbd7fb4143889316_Senate_of_Canada_Standing_Committee_on_Social.pdf
Plasma donation: New thinking to serve Europe’s patients — Practices & approaches for countries
This report presents the case for expanding the availability of blood plasma for the production of plasma-derived medicinal products for patients in all European countries, by growing local donations of plasma.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa24dd835b01dad7b080_Report_Plasma%20donation%20new%20thinking_July21.pdf
Plasma donation: New thinking to serve Europe’s patients — Practices & approaches for countries
This report presents the case for expanding the availability of blood plasma for the production of plasma-derived medicinal products for patients in all European countries, by growing local donations of plasma.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa24dd835b01dad7b080_Report_Plasma%20donation%20new%20thinking_July21.pdf
No results found